BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 136 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $213,000 | -49.0% | 9,374 | -16.5% | 0.03% | -48.0% |
| Q4 2021 | $418,000 | -11.1% | 11,225 | +1.0% | 0.05% | -20.6% |
| Q3 2021 | $470,000 | -5.4% | 11,113 | -0.4% | 0.06% | -7.4% |
| Q2 2021 | $497,000 | +43.2% | 11,158 | +15.7% | 0.07% | +33.3% |
| Q1 2021 | $347,000 | – | 9,642 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
| Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
| Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
| Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
| GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
| Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
| Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
| Penbrook Management LLC | 41,500 | $917,150 | 0.66% |